Episode Details

Back to Episodes
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

Season 26 Episode 251 Published 3 months ago
Description

Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley and Dr Brian M Slomovitz, moderated by Dr O’Malley, including the following topics:

  • Introduction (0:00)
  • Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52)
  • Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16)
  • Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O’Malley (1:00:31)

CME information and select publications

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us